
    
      The purpose of this study is to detect whole chromosome abnormalities on all chromosomes 13,
      16, 18, 21, X and Y, in the fetus through analysis of cell free and compound sample DNA (cf
      DNA and cs DNA, respectively) in maternal blood. In addition, major deletions and
      duplications in chromosomes 1, 4, 5, and 22 will be detected.
    
  